BAM
CL icon

Brave Asset Management’s Colgate-Palmolive CL Stock Holding History

Brave Asset Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-165
Closed -$11K – 437
2014
Q3 		$11K Hold
165
– – 0.01% 344
2014
Q2 		$11K Hold
165
– – 0.01% 352
2014
Q1 		$11K Hold
165
– – 0.01% 347
2013
Q4 		$11K Buy
+165
New +$10.6K 0.01% 342

Other funds holding CL

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brave Asset Management's CL Position: Q4 2014 in Review

Brave Asset Management sold out of Colgate-Palmolive (CL) in Q4 2014, closing a stake of 165 shares — an estimated $11K sold.

Brave Asset Management first reported a position in CL in Q4 2013 and held it in 4 quarters. The position peaked at $11K in Q3 2014. 1,242 funds tracked by Wall St. Rank hold CL as of Q4 2014.

  • Brave Asset Management reported no remaining Colgate-Palmolive position as of Q4 2014 after selling out during the quarter.
  • Brave Asset Management sold 165 Colgate-Palmolive shares in Q4 2014, an estimated $11K.
  • Brave Asset Management first reported a position in Colgate-Palmolive in Q4 2013 and held it in 4 quarters.
  • Brave Asset Management's Colgate-Palmolive position peaked at $11K in Q3 2014.
  • 1,242 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2014.

Based on Brave Asset Management's 13F filing for Q4 2014, filed 2 Feb 2015.